date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.582282781690229.
The log-likelihood improved by 2.844.
Iteration 2 of at most 500:
Optimizing with step length 0.984182311800282.
The log-likelihood improved by 2.761.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 1.469.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.06931.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       8       24     1219     1103      793      318      380      346 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     303      205      138       79       41       24       10        7 
degree17 degree19 
       1        1 
1 
disease_progression 
H-positive risk:  875 854 125 925 429 135 895 426 105 70 105 56 
H-negative risk:  854 875 895 925 426 429 135 125 105 105 56 70 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
56 new agents 
2 
disease_progression 
H-positive risk:  885 853 127 927 427 139 891 417 105 70 103 56 
H-negative risk:  853 885 891 927 417 427 139 127 103 105 56 70 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 1 3 

clinical_engagement 
diagnosis 
demography 
69 new agents 
3 
disease_progression 
H-positive risk:  892 863 131 923 424 141 891 405 107 67 101 55 
H-negative risk:  863 892 891 923 405 424 141 131 101 107 55 67 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 3 4 

clinical_engagement 
diagnosis 
demography 
68 new agents 
4 
disease_progression 
H-positive risk:  900 869 130 912 418 142 893 404 108 68 103 53 
H-negative risk:  869 900 893 912 404 418 142 130 103 108 53 68 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 8 4 

clinical_engagement 
diagnosis 
demography 
51 new agents 
5 
disease_progression 
H-positive risk:  907 871 128 900 420 145 896 402 109 65 104 53 
H-negative risk:  871 907 896 900 402 420 145 128 104 109 53 65 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 10 4 

clinical_engagement 
diagnosis 
demography 
57 new agents 
6 
disease_progression 
H-positive risk:  904 870 129 899 418 146 906 398 109 65 103 53 
H-negative risk:  870 904 906 899 398 418 146 129 103 109 53 65 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 11 7 

clinical_engagement 
diagnosis 
demography 
59 new agents 
7 
disease_progression 
H-positive risk:  913 871 128 894 420 147 907 396 108 63 102 51 
H-negative risk:  871 913 907 894 396 420 147 128 102 108 51 63 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 13 8 

clinical_engagement 
diagnosis 
demography 
57 new agents 
8 
disease_progression 
H-positive risk:  915 874 130 891 414 148 904 395 108 63 104 54 
H-negative risk:  874 915 904 891 395 414 148 130 104 108 54 63 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 16 8 

clinical_engagement 
diagnosis 
demography 
41 new agents 
9 
disease_progression 
H-positive risk:  921 880 128 893 413 146 900 393 107 63 103 53 
H-negative risk:  880 921 900 893 393 413 146 128 103 107 53 63 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 16 8 

clinical_engagement 
diagnosis 
demography 
61 new agents 
10 
disease_progression 
H-positive risk:  931 887 129 892 411 148 891 386 106 63 103 53 
H-negative risk:  887 931 891 892 386 411 148 129 103 106 53 63 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 19 9 

clinical_engagement 
diagnosis 
demography 
63 new agents 
11 
disease_progression 
H-positive risk:  940 897 130 888 404 149 884 385 107 63 100 53 
H-negative risk:  897 940 884 888 385 404 149 130 100 107 53 63 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 21 9 

clinical_engagement 
diagnosis 
demography 
56 new agents 
12 
disease_progression 
H-positive risk:  946 901 132 882 399 153 882 381 110 62 99 53 
H-negative risk:  901 946 882 882 381 399 153 132 99 110 53 62 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 21 9 

clinical_engagement 
diagnosis 
demography 
71 new agents 
13 
disease_progression 
H-positive risk:  855 819 126 969 387 147 976 379 117 62 109 54 
H-negative risk:  819 855 976 969 379 387 147 126 109 117 54 62 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 24 9 

clinical_engagement 
diagnosis 
demography 
211 new agents 
14 
disease_progression 
H-positive risk:  887 858 130 897 428 148 930 395 116 50 104 57 
H-negative risk:  858 887 930 897 395 428 148 130 104 116 57 50 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 26 8 

clinical_engagement 
diagnosis 
demography 
63 new agents 
15 
disease_progression 
H-positive risk:  884 857 130 899 421 146 944 391 115 50 106 57 
H-negative risk:  857 884 944 899 391 421 146 130 106 115 57 50 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 28 8 

clinical_engagement 
diagnosis 
demography 
70 new agents 
16 
disease_progression 
H-positive risk:  887 859 131 891 416 148 952 389 115 49 105 58 
H-negative risk:  859 887 952 891 389 416 148 131 105 115 58 49 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 29 9 

clinical_engagement 
diagnosis 
demography 
73 new agents 
17 
disease_progression 
H-positive risk:  894 868 132 891 413 148 948 386 114 48 104 54 
H-negative risk:  868 894 948 891 386 413 148 132 104 114 54 48 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 29 9 

clinical_engagement 
diagnosis 
demography 
48 new agents 
18 
disease_progression 
H-positive risk:  896 869 133 888 413 147 951 383 114 48 101 57 
H-negative risk:  869 896 951 888 383 413 147 133 101 114 57 48 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 32 8 

clinical_engagement 
diagnosis 
demography 
51 new agents 
19 
disease_progression 
H-positive risk:  901 873 132 884 408 148 953 378 113 49 103 58 
H-negative risk:  873 901 953 884 378 408 148 132 103 113 58 49 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 33 8 

clinical_engagement 
diagnosis 
demography 
45 new agents 
20 
disease_progression 
H-positive risk:  901 873 133 881 407 148 955 375 113 52 103 59 
H-negative risk:  873 901 955 881 375 407 148 133 103 113 59 52 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 34 8 

clinical_engagement 
diagnosis 
demography 
60 new agents 
21 
disease_progression 
H-positive risk:  901 877 130 877 411 151 956 375 114 52 99 57 
H-negative risk:  877 901 956 877 375 411 151 130 99 114 57 52 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 35 8 

clinical_engagement 
diagnosis 
demography 
61 new agents 
22 
disease_progression 
H-positive risk:  906 880 131 876 402 152 956 378 110 52 100 57 
H-negative risk:  880 906 956 876 378 402 152 131 100 110 57 52 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 37 8 

clinical_engagement 
diagnosis 
demography 
74 new agents 
23 
disease_progression 
H-positive risk:  907 886 130 879 401 153 955 372 111 52 99 55 
H-negative risk:  886 907 955 879 372 401 153 130 99 111 55 52 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 38 8 

clinical_engagement 
diagnosis 
demography 
68 new agents 
24 
disease_progression 
H-positive risk:  914 892 130 879 393 152 950 379 107 51 99 54 
H-negative risk:  892 914 950 879 379 393 152 130 99 107 54 51 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 38 11 

clinical_engagement 
diagnosis 
demography 
55 new agents 
25 
disease_progression 
H-positive risk:  846 836 121 937 389 146 1028 375 114 50 107 51 
H-negative risk:  836 846 1028 937 375 389 146 121 107 114 51 50 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 42 12 

clinical_engagement 
diagnosis 
demography 
184 new agents 
26 
disease_progression 
H-positive risk:  872 851 124 894 405 147 990 397 111 54 102 53 
H-negative risk:  851 872 990 894 397 405 147 124 102 111 53 54 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 44 10 

clinical_engagement 
diagnosis 
demography 
71 new agents 
27 
disease_progression 
H-positive risk:  878 855 125 892 403 147 989 391 114 53 100 53 
H-negative risk:  855 878 989 892 391 403 147 125 100 114 53 53 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 46 10 

clinical_engagement 
diagnosis 
demography 
69 new agents 
28 
disease_progression 
H-positive risk:  884 851 127 887 409 143 990 392 114 49 100 54 
H-negative risk:  851 884 990 887 392 409 143 127 100 114 54 49 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 44 13 

clinical_engagement 
diagnosis 
demography 
74 new agents 
29 
disease_progression 
H-positive risk:  888 849 125 890 403 144 997 386 115 50 99 54 
H-negative risk:  849 888 997 890 386 403 144 125 99 115 54 50 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 46 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
30 
disease_progression 
H-positive risk:  886 853 127 890 397 143 993 390 118 49 100 54 
H-negative risk:  853 886 993 890 390 397 143 127 100 118 54 49 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 46 14 

clinical_engagement 
diagnosis 
demography 
65 new agents 
31 
disease_progression 
H-positive risk:  881 858 128 892 393 143 994 392 121 48 98 52 
H-negative risk:  858 881 994 892 392 393 143 128 98 121 52 48 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 46 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
32 
disease_progression 
H-positive risk:  876 870 127 883 389 148 992 393 122 48 98 54 
H-negative risk:  870 876 992 883 393 389 148 127 98 122 54 48 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 46 13 

clinical_engagement 
diagnosis 
demography 
68 new agents 
33 
disease_progression 
H-positive risk:  879 872 128 885 386 147 987 390 122 48 102 54 
H-negative risk:  872 879 987 885 390 386 147 128 102 122 54 48 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 49 14 

clinical_engagement 
diagnosis 
demography 
71 new agents 
34 
disease_progression 
H-positive risk:  879 882 130 881 388 148 980 390 124 46 100 52 
H-negative risk:  882 879 980 881 390 388 148 130 100 124 52 46 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 51 14 

clinical_engagement 
diagnosis 
demography 
71 new agents 
35 
disease_progression 
H-positive risk:  876 897 132 868 388 147 982 390 126 45 98 51 
H-negative risk:  897 876 982 868 390 388 147 132 98 126 51 45 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 54 14 

clinical_engagement 
diagnosis 
demography 
66 new agents 
36 
disease_progression 
H-positive risk:  882 901 132 868 379 148 979 389 126 47 98 51 
H-negative risk:  901 882 979 868 389 379 148 132 98 126 51 47 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 51 14 

clinical_engagement 
diagnosis 
demography 
61 new agents 
37 
disease_progression 
H-positive risk:  822 842 123 943 376 135 1041 381 140 45 104 48 
H-negative risk:  842 822 1041 943 381 376 135 123 104 140 48 45 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 50 14 

clinical_engagement 
diagnosis 
demography 
134 new agents 
38 
disease_progression 
H-positive risk:  843 854 131 919 389 136 984 408 137 46 98 55 
H-negative risk:  854 843 984 919 408 389 136 131 98 137 55 46 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 52 14 

clinical_engagement 
diagnosis 
demography 
92 new agents 
39 
disease_progression 
H-positive risk:  846 850 130 910 390 136 992 402 137 49 103 55 
H-negative risk:  850 846 992 910 402 390 136 130 103 137 55 49 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 55 15 

clinical_engagement 
diagnosis 
demography 
64 new agents 
40 
disease_progression 
H-positive risk:  851 847 129 911 389 136 996 397 137 50 104 53 
H-negative risk:  847 851 996 911 397 389 136 129 104 137 53 50 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 58 14 

clinical_engagement 
diagnosis 
demography 
66 new agents 
41 
disease_progression 
H-positive risk:  857 848 129 911 383 137 995 396 136 51 105 52 
H-negative risk:  848 857 995 911 396 383 137 129 105 136 52 51 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 55 16 

clinical_engagement 
diagnosis 
demography 
56 new agents 
42 
disease_progression 
H-positive risk:  863 845 130 909 378 138 996 396 135 51 107 52 
H-negative risk:  845 863 996 909 396 378 138 130 107 135 52 51 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 54 16 

clinical_engagement 
diagnosis 
demography 
59 new agents 
43 
disease_progression 
H-positive risk:  862 845 130 905 375 142 998 401 136 48 108 50 
H-negative risk:  845 862 998 905 401 375 142 130 108 136 50 48 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 56 16 

clinical_engagement 
diagnosis 
demography 
56 new agents 
44 
disease_progression 
H-positive risk:  864 849 131 901 373 143 999 402 133 47 109 49 
H-negative risk:  849 864 999 901 402 373 143 131 109 133 49 47 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 57 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
45 
disease_progression 
H-positive risk:  867 852 134 903 368 142 998 393 135 50 107 51 
H-negative risk:  852 867 998 903 393 368 142 134 107 135 51 50 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 60 18 

clinical_engagement 
diagnosis 
demography 
52 new agents 
46 
disease_progression 
H-positive risk:  868 853 135 905 369 142 992 393 134 50 108 51 
H-negative risk:  853 868 992 905 393 369 142 135 108 134 51 50 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 58 17 

clinical_engagement 
diagnosis 
demography 
60 new agents 
47 
disease_progression 
H-positive risk:  863 859 133 907 374 143 988 390 131 54 109 49 
H-negative risk:  859 863 988 907 390 374 143 133 109 131 49 54 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 59 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
48 
disease_progression 
H-positive risk:  864 854 132 907 378 143 987 387 134 54 111 49 
H-negative risk:  854 864 987 907 387 378 143 132 111 134 49 54 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 59 17 

clinical_engagement 
diagnosis 
demography 
62 new agents 
49 
disease_progression 
H-positive risk:  812 807 122 952 380 138 1046 380 139 54 122 48 
H-negative risk:  807 812 1046 952 380 380 138 122 122 139 48 54 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 58 17 

clinical_engagement 
diagnosis 
demography 
144 new agents 
50 
disease_progression 
H-positive risk:  813 820 123 928 396 137 1023 403 137 55 121 44 
H-negative risk:  820 813 1023 928 403 396 137 123 121 137 44 55 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 55 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
51 
disease_progression 
H-positive risk:  808 825 123 925 397 140 1021 406 136 56 121 42 
H-negative risk:  825 808 1021 925 406 397 140 123 121 136 42 56 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 56 17 

clinical_engagement 
diagnosis 
demography 
61 new agents 
52 
disease_progression 
H-positive risk:  803 836 123 923 396 140 1014 407 137 56 122 43 
H-negative risk:  836 803 1014 923 407 396 140 123 122 137 43 56 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 56 17 

clinical_engagement 
diagnosis 
demography 
64 new agents 
53 
disease_progression 
H-positive risk:  802 843 124 926 389 140 1013 404 139 57 122 41 
H-negative risk:  843 802 1013 926 404 389 140 124 122 139 41 57 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 56 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
54 
disease_progression 
H-positive risk:  805 846 127 921 393 144 1010 395 140 53 124 42 
H-negative risk:  846 805 1010 921 395 393 144 127 124 140 42 53 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 61 15 

clinical_engagement 
diagnosis 
demography 
64 new agents 
55 
disease_progression 
H-positive risk:  807 844 131 918 391 145 1012 393 143 53 122 41 
H-negative risk:  844 807 1012 918 393 391 145 131 122 143 41 53 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 63 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
56 
disease_progression 
H-positive risk:  807 854 131 920 392 144 1009 384 141 53 125 40 
H-negative risk:  854 807 1009 920 384 392 144 131 125 141 40 53 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
79 new agents 
57 
disease_progression 
H-positive risk:  806 862 133 920 392 144 1015 377 138 51 124 38 
H-negative risk:  862 806 1015 920 377 392 144 133 124 138 38 51 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
64 new agents 
58 
disease_progression 
H-positive risk:  807 864 129 922 392 145 1011 377 138 48 128 39 
H-negative risk:  864 807 1011 922 377 392 145 129 128 138 39 48 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
59 
disease_progression 
H-positive risk:  809 876 130 917 387 151 1005 376 138 46 125 40 
H-negative risk:  876 809 1005 917 376 387 151 130 125 138 40 46 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 72 16 

clinical_engagement 
diagnosis 
demography 
91 new agents 
60 
disease_progression 
H-positive risk:  812 871 129 916 387 152 1008 377 145 43 125 35 
H-negative risk:  871 812 1008 916 377 387 152 129 125 145 35 43 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 73 14 

clinical_engagement 
diagnosis 
demography 
66 new agents 
61 
disease_progression 
H-positive risk:  763 815 122 960 382 145 1067 382 151 43 135 35 
H-negative risk:  815 763 1067 960 382 382 145 122 135 151 35 43 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
142 new agents 
62 
disease_progression 
H-positive risk:  774 820 121 943 395 143 1040 393 154 43 136 38 
H-negative risk:  820 774 1040 943 393 395 143 121 136 154 38 43 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 70 19 

clinical_engagement 
diagnosis 
demography 
91 new agents 
63 
disease_progression 
H-positive risk:  782 826 118 935 394 142 1047 383 154 44 137 38 
H-negative risk:  826 782 1047 935 383 394 142 118 137 154 38 44 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 67 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
64 
disease_progression 
H-positive risk:  775 823 118 939 387 141 1050 390 155 48 136 38 
H-negative risk:  823 775 1050 939 390 387 141 118 136 155 38 48 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 68 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
65 
disease_progression 
H-positive risk:  778 826 118 936 387 140 1049 388 152 50 137 39 
H-negative risk:  826 778 1049 936 388 387 140 118 137 152 39 50 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
66 
disease_progression 
H-positive risk:  777 830 117 933 386 136 1053 384 153 52 140 39 
H-negative risk:  830 777 1053 933 384 386 136 117 140 153 39 52 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
67 
disease_progression 
H-positive risk:  779 832 117 934 380 135 1045 389 156 55 137 41 
H-negative risk:  832 779 1045 934 389 380 135 117 137 156 41 55 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
68 
disease_progression 
H-positive risk:  784 831 115 938 380 134 1040 390 156 54 135 43 
H-negative risk:  831 784 1040 938 390 380 134 115 135 156 43 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
69 
disease_progression 
H-positive risk:  788 833 111 938 377 134 1043 390 154 53 135 44 
H-negative risk:  833 788 1043 938 390 377 134 111 135 154 44 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
70 
disease_progression 
H-positive risk:  786 833 110 936 379 131 1048 389 153 53 139 43 
H-negative risk:  833 786 1048 936 389 379 131 110 139 153 43 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
71 
disease_progression 
H-positive risk:  783 837 111 943 385 126 1046 381 155 53 139 41 
H-negative risk:  837 783 1046 943 381 385 126 111 139 155 41 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
72 
disease_progression 
H-positive risk:  789 840 109 941 382 127 1042 382 155 52 139 42 
H-negative risk:  840 789 1042 941 382 382 127 109 139 155 42 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
73 
disease_progression 
H-positive risk:  757 779 106 1002 382 117 1080 380 163 52 141 41 
H-negative risk:  779 757 1080 1002 380 382 117 106 141 163 41 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
144 new agents 
74 
disease_progression 
H-positive risk:  763 791 104 988 372 120 1073 393 162 51 141 42 
H-negative risk:  791 763 1073 988 393 372 120 104 141 162 42 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
75 
disease_progression 
H-positive risk:  765 790 106 984 372 123 1073 390 162 50 138 47 
H-negative risk:  790 765 1073 984 390 372 123 106 138 162 47 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
76 
disease_progression 
H-positive risk:  766 799 104 982 368 127 1068 390 160 53 136 47 
H-negative risk:  799 766 1068 982 390 368 127 104 136 160 47 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
77 
disease_progression 
H-positive risk:  763 802 104 980 372 124 1072 382 161 55 138 47 
H-negative risk:  802 763 1072 980 382 372 124 104 138 161 47 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
54 new agents 
78 
disease_progression 
H-positive risk:  763 794 102 987 373 126 1075 380 160 53 141 46 
H-negative risk:  794 763 1075 987 380 373 126 102 141 160 46 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
79 
disease_progression 
H-positive risk:  767 796 102 985 377 125 1076 377 158 51 140 46 
H-negative risk:  796 767 1076 985 377 377 125 102 140 158 46 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
80 
disease_progression 
H-positive risk:  767 790 100 987 387 125 1069 381 158 51 142 43 
H-negative risk:  790 767 1069 987 381 387 125 100 142 158 43 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
81 
disease_progression 
H-positive risk:  774 791 100 995 385 124 1057 381 155 51 144 43 
H-negative risk:  791 774 1057 995 381 385 124 100 144 155 43 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
82 
disease_progression 
H-positive risk:  776 793 99 994 386 123 1064 377 153 48 147 40 
H-negative risk:  793 776 1064 994 377 386 123 99 147 153 40 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
83 
disease_progression 
H-positive risk:  782 795 102 988 381 126 1059 372 156 48 149 42 
H-negative risk:  795 782 1059 988 372 381 126 102 149 156 42 48 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
84 
disease_progression 
H-positive risk:  783 801 104 986 371 132 1056 374 150 47 153 43 
H-negative risk:  801 783 1056 986 374 371 132 104 153 150 43 47 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
85 
disease_progression 
H-positive risk:  738 765 102 1025 373 128 1105 370 157 46 149 42 
H-negative risk:  765 738 1105 1025 370 373 128 102 149 157 42 46 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
108 new agents 
86 
disease_progression 
H-positive risk:  745 760 102 1017 389 129 1080 376 156 48 151 47 
H-negative risk:  760 745 1080 1017 376 389 129 102 151 156 47 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
93 new agents 
87 
disease_progression 
H-positive risk:  747 763 99 1021 376 127 1086 379 159 47 148 48 
H-negative risk:  763 747 1086 1021 379 376 127 99 148 159 48 47 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
88 
disease_progression 
H-positive risk:  749 768 98 1028 368 126 1081 380 159 46 149 48 
H-negative risk:  768 749 1081 1028 380 368 126 98 149 159 48 46 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
89 
disease_progression 
H-positive risk:  754 766 98 1034 362 127 1083 378 157 46 149 46 
H-negative risk:  766 754 1083 1034 378 362 127 98 149 157 46 46 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
90 
disease_progression 
H-positive risk:  758 758 97 1036 353 127 1077 389 158 43 155 49 
H-negative risk:  758 758 1077 1036 389 353 127 97 155 158 49 43 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 91 29 

clinical_engagement 
diagnosis 
demography 
60 new agents 
91 
disease_progression 
H-positive risk:  751 764 98 1041 353 127 1078 388 156 42 152 50 
H-negative risk:  764 751 1078 1041 388 353 127 98 152 156 50 42 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
92 
disease_progression 
H-positive risk:  747 762 100 1050 345 124 1078 392 158 40 153 51 
H-negative risk:  762 747 1078 1050 392 345 124 100 153 158 51 40 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
93 
disease_progression 
H-positive risk:  750 760 98 1053 349 125 1073 392 158 40 149 53 
H-negative risk:  760 750 1073 1053 392 349 125 98 149 158 53 40 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
94 
disease_progression 
H-positive risk:  757 763 98 1049 347 125 1070 394 157 39 148 53 
H-negative risk:  763 757 1070 1049 394 347 125 98 148 157 53 39 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
95 
disease_progression 
H-positive risk:  764 760 101 1048 353 123 1057 398 154 38 149 55 
H-negative risk:  760 764 1057 1048 398 353 123 101 149 154 55 38 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
96 
disease_progression 
H-positive risk:  763 757 101 1039 356 119 1065 399 158 37 152 54 
H-negative risk:  757 763 1065 1039 399 356 119 101 152 158 54 37 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
97 
disease_progression 
H-positive risk:  706 714 96 1090 354 109 1116 399 169 37 154 56 
H-negative risk:  714 706 1116 1090 399 354 109 96 154 169 56 37 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
98 
disease_progression 
H-positive risk:  698 716 98 1082 371 107 1104 404 169 41 154 56 
H-negative risk:  716 698 1104 1082 404 371 107 98 154 169 56 41 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
99 
disease_progression 
H-positive risk:  693 721 101 1080 371 107 1106 403 169 41 149 59 
H-negative risk:  721 693 1106 1080 403 371 107 101 149 169 59 41 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
100 
disease_progression 
H-positive risk:  693 717 103 1086 366 105 1108 406 167 41 149 59 
H-negative risk:  717 693 1108 1086 406 366 105 103 149 167 59 41 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
101 
disease_progression 
H-positive risk:  695 714 104 1085 364 106 1112 403 168 42 149 58 
H-negative risk:  714 695 1112 1085 403 364 106 104 149 168 58 42 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
102 
disease_progression 
H-positive risk:  699 719 104 1080 359 109 1118 397 169 44 144 58 
H-negative risk:  719 699 1118 1080 397 359 109 104 144 169 58 44 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
103 
disease_progression 
H-positive risk:  703 717 105 1067 364 109 1125 398 171 44 139 58 
H-negative risk:  717 703 1125 1067 398 364 109 105 139 171 58 44 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
104 
disease_progression 
H-positive risk:  707 718 104 1062 368 112 1120 394 172 47 139 57 
H-negative risk:  718 707 1120 1062 394 368 112 104 139 172 57 47 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 98 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
105 
disease_progression 
H-positive risk:  710 716 105 1070 359 113 1116 391 177 47 140 56 
H-negative risk:  716 710 1116 1070 391 359 113 105 140 177 56 47 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 99 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
106 
disease_progression 
H-positive risk:  705 714 108 1069 359 113 1126 385 179 46 141 55 
H-negative risk:  714 705 1126 1069 385 359 113 108 141 179 55 46 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 97 25 

clinical_engagement 
diagnosis 
demography 
61 new agents 
107 
disease_progression 
H-positive risk:  699 707 109 1076 353 113 1134 387 178 47 143 54 
H-negative risk:  707 699 1134 1076 387 353 113 109 143 178 54 47 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 95 27 

clinical_engagement 
diagnosis 
demography 
87 new agents 
108 
disease_progression 
H-positive risk:  708 716 106 1084 347 113 1134 371 170 50 145 56 
H-negative risk:  716 708 1134 1084 371 347 113 106 145 170 56 50 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 97 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
109 
disease_progression 
H-positive risk:  675 687 97 1119 349 106 1164 365 177 51 153 57 
H-negative risk:  687 675 1164 1119 365 349 106 97 153 177 57 51 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 100 24 

clinical_engagement 
diagnosis 
demography 
94 new agents 
110 
disease_progression 
H-positive risk:  669 673 99 1107 372 108 1158 376 175 52 154 57 
H-negative risk:  673 669 1158 1107 376 372 108 99 154 175 57 52 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 98 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
111 
disease_progression 
H-positive risk:  671 680 99 1106 377 106 1148 378 172 52 154 57 
H-negative risk:  680 671 1148 1106 378 377 106 99 154 172 57 52 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
112 
disease_progression 
H-positive risk:  676 683 99 1102 387 105 1142 374 171 53 153 55 
H-negative risk:  683 676 1142 1102 374 387 105 99 153 171 55 53 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 100 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
113 
disease_progression 
H-positive risk:  674 680 99 1104 384 103 1152 371 170 54 152 57 
H-negative risk:  680 674 1152 1104 371 384 103 99 152 170 57 54 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 97 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
114 
disease_progression 
H-positive risk:  669 680 99 1112 381 104 1148 371 172 55 151 58 
H-negative risk:  680 669 1148 1112 371 381 104 99 151 172 58 55 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 97 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
115 
disease_progression 
H-positive risk:  668 680 98 1117 374 103 1146 376 171 55 152 60 
H-negative risk:  680 668 1146 1117 376 374 103 98 152 171 60 55 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 97 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
116 
disease_progression 
H-positive risk:  672 679 99 1118 367 102 1154 376 174 53 148 58 
H-negative risk:  679 672 1154 1118 376 367 102 99 148 174 58 53 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 96 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
117 
disease_progression 
H-positive risk:  676 681 96 1115 364 103 1159 372 175 52 147 60 
H-negative risk:  681 676 1159 1115 372 364 103 96 147 175 60 52 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 98 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
118 
disease_progression 
H-positive risk:  681 678 96 1114 364 103 1160 371 177 51 148 57 
H-negative risk:  678 681 1160 1114 371 364 103 96 148 177 57 51 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 95 30 

clinical_engagement 
diagnosis 
demography 
67 new agents 
119 
disease_progression 
H-positive risk:  685 672 97 1120 361 102 1158 371 179 50 147 58 
H-negative risk:  672 685 1158 1120 371 361 102 97 147 179 58 50 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
120 
disease_progression 
H-positive risk:  684 668 97 1128 360 103 1155 368 179 52 147 59 
H-negative risk:  668 684 1155 1128 368 360 103 97 147 179 59 52 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
83 new agents 
121 
disease_progression 
H-positive risk:  639 635 93 1172 367 98 1184 363 186 52 150 61 
H-negative risk:  635 639 1184 1172 363 367 98 93 150 186 61 52 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
95 new agents 
122 
disease_progression 
H-positive risk:  638 647 93 1156 379 99 1168 374 186 50 147 63 
H-negative risk:  647 638 1168 1156 374 379 99 93 147 186 63 50 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 90 31 

clinical_engagement 
diagnosis 
demography 
86 new agents 
123 
disease_progression 
H-positive risk:  645 654 93 1147 375 102 1161 377 186 50 145 65 
H-negative risk:  654 645 1161 1147 377 375 102 93 145 186 65 50 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 90 31 

clinical_engagement 
diagnosis 
demography 
65 new agents 
124 
disease_progression 
H-positive risk:  645 660 91 1145 378 101 1159 374 187 51 148 61 
H-negative risk:  660 645 1159 1145 374 378 101 91 148 187 61 51 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 91 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
125 
disease_progression 
H-positive risk:  648 658 89 1151 376 101 1160 369 186 51 150 61 
H-negative risk:  658 648 1160 1151 369 376 101 89 150 186 61 51 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 92 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
126 
disease_progression 
H-positive risk:  657 664 86 1144 382 97 1156 366 184 48 152 64 
H-negative risk:  664 657 1156 1144 366 382 97 86 152 184 64 48 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 95 30 

clinical_engagement 
diagnosis 
demography 
68 new agents 
127 
disease_progression 
H-positive risk:  663 666 86 1145 380 98 1157 360 181 46 150 68 
H-negative risk:  666 663 1157 1145 360 380 98 86 150 181 68 46 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 97 30 

clinical_engagement 
diagnosis 
demography 
63 new agents 
128 
disease_progression 
H-positive risk:  667 671 86 1138 381 96 1155 358 178 49 150 71 
H-negative risk:  671 667 1155 1138 358 381 96 86 150 178 71 49 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 99 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
129 
disease_progression 
H-positive risk:  661 673 87 1132 383 96 1159 357 179 49 152 72 
H-negative risk:  673 661 1159 1132 357 383 96 87 152 179 72 49 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 99 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
130 
disease_progression 
H-positive risk:  658 663 84 1143 386 97 1158 362 179 49 151 70 
H-negative risk:  663 658 1158 1143 362 386 97 84 151 179 70 49 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 96 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
131 
disease_progression 
H-positive risk:  667 661 85 1140 383 95 1160 363 177 51 149 69 
H-negative risk:  661 667 1160 1140 363 383 95 85 149 177 69 51 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 95 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
132 
disease_progression 
H-positive risk:  667 664 87 1143 385 94 1167 352 176 50 148 67 
H-negative risk:  664 667 1167 1143 352 385 94 87 148 176 67 50 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 93 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
133 
disease_progression 
H-positive risk:  668 661 88 1134 390 91 1167 353 182 49 149 68 
H-negative risk:  661 668 1167 1134 353 390 91 88 149 182 68 49 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 93 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
134 
disease_progression 
H-positive risk:  658 658 86 1131 394 93 1174 353 181 51 152 69 
H-negative risk:  658 658 1174 1131 353 394 93 86 152 181 69 51 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
85 new agents 
135 
disease_progression 
H-positive risk:  666 658 86 1128 392 96 1169 354 179 51 150 71 
H-negative risk:  658 666 1169 1128 354 392 96 86 150 179 71 51 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
136 
disease_progression 
H-positive risk:  666 657 87 1131 384 95 1165 359 181 53 152 70 
H-negative risk:  657 666 1165 1131 359 384 95 87 152 181 70 53 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 92 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
137 
disease_progression 
H-positive risk:  653 659 88 1132 382 94 1173 359 182 55 151 72 
H-negative risk:  659 653 1173 1132 359 382 94 88 151 182 72 55 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 93 28 

clinical_engagement 
diagnosis 
demography 
70 new agents 
138 
disease_progression 
H-positive risk:  660 654 88 1133 383 97 1170 363 178 53 150 71 
H-negative risk:  654 660 1170 1133 363 383 97 88 150 178 71 53 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 93 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
139 
disease_progression 
H-positive risk:  659 663 89 1134 379 97 1176 356 181 53 145 68 
H-negative risk:  663 659 1176 1134 356 379 97 89 145 181 68 53 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 95 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
140 
disease_progression 
H-positive risk:  658 658 91 1141 377 95 1171 360 180 52 149 68 
H-negative risk:  658 658 1171 1141 360 377 95 91 149 180 68 52 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 95 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
141 
disease_progression 
H-positive risk:  660 659 91 1143 384 92 1162 361 181 52 150 65 
H-negative risk:  659 660 1162 1143 361 384 92 91 150 181 65 52 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 94 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
142 
disease_progression 
H-positive risk:  664 660 91 1149 372 93 1159 369 178 52 151 62 
H-negative risk:  660 664 1159 1149 369 372 93 91 151 178 62 52 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 96 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
143 
disease_progression 
H-positive risk:  658 670 88 1154 363 91 1160 373 175 53 154 61 
H-negative risk:  670 658 1160 1154 373 363 91 88 154 175 61 53 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
144 
disease_progression 
H-positive risk:  658 674 87 1154 362 90 1153 375 177 54 154 62 
H-negative risk:  674 658 1153 1154 375 362 90 87 154 177 62 54 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
145 
disease_progression 
H-positive risk:  658 686 85 1152 357 93 1157 369 173 55 152 63 
H-negative risk:  686 658 1157 1152 369 357 93 85 152 173 63 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
94 new agents 
146 
disease_progression 
H-positive risk:  664 682 85 1155 357 92 1147 372 175 56 151 64 
H-negative risk:  682 664 1147 1155 372 357 92 85 151 175 64 56 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 92 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
147 
disease_progression 
H-positive risk:  662 682 84 1152 361 93 1141 383 177 55 151 59 
H-negative risk:  682 662 1141 1152 383 361 93 84 151 177 59 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
148 
disease_progression 
H-positive risk:  661 681 82 1151 372 94 1137 385 177 52 152 56 
H-negative risk:  681 661 1137 1151 385 372 94 82 152 177 56 52 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 93 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
149 
disease_progression 
H-positive risk:  671 674 81 1155 368 95 1142 377 174 51 154 58 
H-negative risk:  674 671 1142 1155 377 368 95 81 154 174 58 51 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
150 
disease_progression 
H-positive risk:  671 680 81 1145 370 94 1148 379 172 48 155 57 
H-negative risk:  680 671 1148 1145 379 370 94 81 155 172 57 48 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
151 
disease_progression 
H-positive risk:  672 679 80 1150 361 96 1147 379 172 52 153 59 
H-negative risk:  679 672 1147 1150 379 361 96 80 153 172 59 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
152 
disease_progression 
H-positive risk:  679 672 78 1153 374 96 1139 372 169 53 155 60 
H-negative risk:  672 679 1139 1153 372 374 96 78 155 169 60 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
153 
disease_progression 
H-positive risk:  675 675 76 1151 371 99 1135 378 167 55 157 61 
H-negative risk:  675 675 1135 1151 378 371 99 76 157 167 61 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
154 
disease_progression 
H-positive risk:  680 669 79 1157 377 99 1124 373 162 60 159 61 
H-negative risk:  669 680 1124 1157 373 377 99 79 159 162 61 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
155 
disease_progression 
H-positive risk:  689 667 80 1154 379 98 1119 364 167 60 161 62 
H-negative risk:  667 689 1119 1154 364 379 98 80 161 167 62 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
156 
disease_progression 
H-positive risk:  697 671 82 1157 370 98 1118 363 166 57 159 62 
H-negative risk:  671 697 1118 1157 363 370 98 82 159 166 62 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
157 
disease_progression 
H-positive risk:  691 677 79 1158 372 100 1114 365 167 57 161 59 
H-negative risk:  677 691 1114 1158 365 372 100 79 161 167 59 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
158 
disease_progression 
H-positive risk:  695 668 78 1147 387 99 1106 370 165 64 163 58 
H-negative risk:  668 695 1106 1147 370 387 99 78 163 165 58 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
159 
disease_progression 
H-positive risk:  688 658 75 1161 389 99 1111 369 165 64 164 57 
H-negative risk:  658 688 1111 1161 369 389 99 75 164 165 57 64 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
160 
disease_progression 
H-positive risk:  686 654 74 1161 388 99 1119 368 161 65 168 57 
H-negative risk:  654 686 1119 1161 368 388 99 74 168 161 57 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
161 
disease_progression 
H-positive risk:  686 650 76 1158 384 99 1122 372 161 65 167 60 
H-negative risk:  650 686 1122 1158 372 384 99 76 167 161 60 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
162 
disease_progression 
H-positive risk:  683 652 81 1152 396 97 1122 368 161 66 164 58 
H-negative risk:  652 683 1122 1152 368 396 97 81 164 161 58 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
163 
disease_progression 
H-positive risk:  677 658 82 1152 394 98 1125 365 163 65 164 57 
H-negative risk:  658 677 1125 1152 365 394 98 82 164 163 57 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
164 
disease_progression 
H-positive risk:  674 654 83 1153 393 100 1132 367 163 62 161 58 
H-negative risk:  654 674 1132 1153 367 393 100 83 161 163 58 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
165 
disease_progression 
H-positive risk:  676 658 83 1148 393 99 1135 365 165 60 160 58 
H-negative risk:  658 676 1135 1148 365 393 99 83 160 165 58 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
166 
disease_progression 
H-positive risk:  678 666 87 1151 390 98 1132 361 162 62 158 55 
H-negative risk:  666 678 1132 1151 361 390 98 87 158 162 55 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
167 
disease_progression 
H-positive risk:  674 660 88 1155 389 94 1137 358 170 62 158 55 
H-negative risk:  660 674 1137 1155 358 389 94 88 158 170 55 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
168 
disease_progression 
H-positive risk:  662 659 85 1161 386 92 1146 361 172 61 157 58 
H-negative risk:  659 662 1146 1161 361 386 92 85 157 172 58 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
169 
disease_progression 
H-positive risk:  662 656 87 1172 382 90 1150 359 168 63 155 56 
H-negative risk:  656 662 1150 1172 359 382 90 87 155 168 56 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
170 
disease_progression 
H-positive risk:  670 649 85 1173 388 89 1140 369 166 63 152 56 
H-negative risk:  649 670 1140 1173 369 388 89 85 152 166 56 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
171 
disease_progression 
H-positive risk:  661 653 86 1174 390 89 1145 364 165 65 152 56 
H-negative risk:  653 661 1145 1174 364 390 89 86 152 165 56 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
172 
disease_progression 
H-positive risk:  661 658 86 1169 389 89 1144 368 163 62 153 58 
H-negative risk:  658 661 1144 1169 368 389 89 86 153 163 58 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
173 
disease_progression 
H-positive risk:  655 659 82 1158 390 87 1151 380 162 61 158 57 
H-negative risk:  659 655 1151 1158 380 390 87 82 158 162 57 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
174 
disease_progression 
H-positive risk:  651 662 84 1153 396 90 1146 379 164 60 158 57 
H-negative risk:  662 651 1146 1153 379 396 90 84 158 164 57 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
175 
disease_progression 
H-positive risk:  653 662 83 1156 399 91 1145 376 165 58 159 53 
H-negative risk:  662 653 1145 1156 376 399 91 83 159 165 53 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 93 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
176 
disease_progression 
H-positive risk:  653 651 83 1161 405 91 1147 377 165 56 158 53 
H-negative risk:  651 653 1147 1161 377 405 91 83 158 165 53 56 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
177 
disease_progression 
H-positive risk:  655 651 85 1157 405 89 1145 377 165 56 162 53 
H-negative risk:  651 655 1145 1157 377 405 89 85 162 165 53 56 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
178 
disease_progression 
H-positive risk:  658 654 84 1156 410 86 1129 387 163 57 162 54 
H-negative risk:  654 658 1129 1156 387 410 86 84 162 163 54 57 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 101 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
179 
disease_progression 
H-positive risk:  656 655 85 1153 408 84 1127 395 162 58 165 52 
H-negative risk:  655 656 1127 1153 395 408 84 85 165 162 52 58 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 100 19 

clinical_engagement 
diagnosis 
demography 
89 new agents 
180 
disease_progression 
H-positive risk:  654 655 88 1146 413 84 1133 393 163 54 166 51 
H-negative risk:  655 654 1133 1146 393 413 84 88 166 163 51 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 99 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
181 
disease_progression 
H-positive risk:  653 658 88 1151 415 83 1135 388 164 52 164 49 
H-negative risk:  658 653 1135 1151 388 415 83 88 164 164 49 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 99 18 

clinical_engagement 
diagnosis 
demography 
95 new agents 
182 
disease_progression 
H-positive risk:  653 650 90 1139 428 78 1140 397 165 50 162 48 
H-negative risk:  650 653 1140 1139 397 428 78 90 162 165 48 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 97 19 

clinical_engagement 
diagnosis 
demography 
100 new agents 
183 
disease_progression 
H-positive risk:  659 649 89 1143 432 80 1136 389 157 54 166 46 
H-negative risk:  649 659 1136 1143 389 432 80 89 166 157 46 54 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 96 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
184 
disease_progression 
H-positive risk:  660 646 88 1146 437 80 1128 385 158 54 174 44 
H-negative risk:  646 660 1128 1146 385 437 80 88 174 158 44 54 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 96 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
185 
disease_progression 
H-positive risk:  668 644 88 1144 441 82 1117 387 156 55 174 44 
H-negative risk:  644 668 1117 1144 387 441 82 88 174 156 44 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 95 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
186 
disease_progression 
H-positive risk:  674 643 86 1144 442 80 1111 389 157 57 173 44 
H-negative risk:  643 674 1111 1144 389 442 80 86 173 157 44 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 96 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
187 
disease_progression 
H-positive risk:  682 640 84 1137 440 78 1106 398 158 57 174 46 
H-negative risk:  640 682 1106 1137 398 440 78 84 174 158 46 57 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
188 
disease_progression 
H-positive risk:  673 647 82 1133 432 81 1115 404 154 60 173 46 
H-negative risk:  647 673 1115 1133 404 432 81 82 173 154 46 60 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
189 
disease_progression 
H-positive risk:  676 646 81 1138 426 81 1122 397 154 59 173 47 
H-negative risk:  646 676 1122 1138 397 426 81 81 173 154 47 59 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 97 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
190 
disease_progression 
H-positive risk:  670 645 82 1151 426 80 1118 397 151 55 174 51 
H-negative risk:  645 670 1118 1151 397 426 80 82 174 151 51 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
191 
disease_progression 
H-positive risk:  675 647 83 1142 429 83 1122 390 153 49 176 51 
H-negative risk:  647 675 1122 1142 390 429 83 83 176 153 51 49 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
192 
disease_progression 
H-positive risk:  680 645 84 1147 431 82 1118 388 154 46 176 49 
H-negative risk:  645 680 1118 1147 388 431 82 84 176 154 49 46 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
193 
disease_progression 
H-positive risk:  670 650 81 1153 433 80 1124 393 148 45 176 47 
H-negative risk:  650 670 1124 1153 393 433 80 81 176 148 47 45 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
194 
disease_progression 
H-positive risk:  669 647 84 1148 439 79 1120 397 151 45 173 48 
H-negative risk:  647 669 1120 1148 397 439 79 84 173 151 48 45 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
195 
disease_progression 
H-positive risk:  669 640 83 1147 440 80 1121 405 150 45 173 47 
H-negative risk:  640 669 1121 1147 405 440 80 83 173 150 47 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
196 
disease_progression 
H-positive risk:  677 637 84 1137 440 79 1122 408 149 47 173 47 
H-negative risk:  637 677 1122 1137 408 440 79 84 173 149 47 47 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
197 
disease_progression 
H-positive risk:  679 632 85 1139 446 77 1120 403 150 45 174 50 
H-negative risk:  632 679 1120 1139 403 446 77 85 174 150 50 45 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
198 
disease_progression 
H-positive risk:  681 635 87 1132 449 77 1116 409 148 44 172 50 
H-negative risk:  635 681 1116 1132 409 449 77 87 172 148 50 44 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
108 new agents 
199 
disease_progression 
H-positive risk:  686 646 90 1124 437 78 1108 417 151 43 171 49 
H-negative risk:  646 686 1108 1124 417 437 78 90 171 151 49 43 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
200 
disease_progression 
H-positive risk:  688 655 89 1118 435 76 1104 416 151 46 174 48 
H-negative risk:  655 688 1104 1118 416 435 76 89 174 151 48 46 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
201 
disease_progression 
H-positive risk:  685 656 90 1120 436 79 1103 412 150 45 173 51 
H-negative risk:  656 685 1103 1120 412 436 79 90 173 150 51 45 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 95 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
202 
disease_progression 
H-positive risk:  691 655 89 1122 434 81 1096 411 150 45 177 49 
H-negative risk:  655 691 1096 1122 411 434 81 89 177 150 49 45 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
203 
disease_progression 
H-positive risk:  686 653 88 1129 441 80 1091 413 149 47 171 52 
H-negative risk:  653 686 1091 1129 413 441 80 88 171 149 52 47 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
204 
disease_progression 
H-positive risk:  683 657 87 1125 444 81 1099 406 150 45 170 53 
H-negative risk:  657 683 1099 1125 406 444 81 87 170 150 53 45 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
205 
disease_progression 
H-positive risk:  689 650 87 1124 443 77 1103 409 153 45 169 51 
H-negative risk:  650 689 1103 1124 409 443 77 87 169 153 51 45 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 93 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
206 
disease_progression 
H-positive risk:  687 646 87 1123 451 79 1095 413 151 49 165 54 
H-negative risk:  646 687 1095 1123 413 451 79 87 165 151 54 49 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
207 
disease_progression 
H-positive risk:  687 644 90 1118 461 78 1084 420 150 48 162 58 
H-negative risk:  644 687 1084 1118 420 461 78 90 162 150 58 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
208 
disease_progression 
H-positive risk:  681 646 93 1117 459 80 1097 411 151 50 159 56 
H-negative risk:  646 681 1097 1117 411 459 80 93 159 151 56 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
209 
disease_progression 
H-positive risk:  688 655 98 1110 453 78 1097 408 151 50 158 54 
H-negative risk:  655 688 1097 1110 408 453 78 98 158 151 54 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
210 
disease_progression 
H-positive risk:  691 661 99 1110 453 79 1086 405 151 49 157 59 
H-negative risk:  661 691 1086 1110 405 453 79 99 157 151 59 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
211 
disease_progression 
H-positive risk:  693 661 100 1106 453 81 1086 408 149 52 154 57 
H-negative risk:  661 693 1086 1106 408 453 81 100 154 149 57 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
212 
disease_progression 
H-positive risk:  699 662 99 1105 448 80 1087 409 150 52 152 57 
H-negative risk:  662 699 1087 1105 409 448 80 99 152 150 57 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
213 
disease_progression 
H-positive risk:  686 666 98 1117 446 81 1092 412 150 49 153 50 
H-negative risk:  666 686 1092 1117 412 446 81 98 153 150 50 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
214 
disease_progression 
H-positive risk:  678 661 100 1116 451 81 1098 412 154 47 153 49 
H-negative risk:  661 678 1098 1116 412 451 81 100 153 154 49 47 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
215 
disease_progression 
H-positive risk:  681 665 98 1117 449 83 1099 410 155 44 147 52 
H-negative risk:  665 681 1099 1117 410 449 83 98 147 155 52 44 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
216 
disease_progression 
H-positive risk:  684 666 98 1120 450 86 1088 410 154 44 148 52 
H-negative risk:  666 684 1088 1120 410 450 86 98 148 154 52 44 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
59 new agents 
217 
disease_progression 
H-positive risk:  684 663 97 1111 461 87 1076 419 154 47 146 55 
H-negative risk:  663 684 1076 1111 419 461 87 97 146 154 55 47 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
218 
disease_progression 
H-positive risk:  686 665 97 1107 454 86 1087 421 152 44 146 55 
H-negative risk:  665 686 1087 1107 421 454 86 97 146 152 55 44 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
219 
disease_progression 
H-positive risk:  682 660 94 1119 451 87 1094 420 151 42 144 56 
H-negative risk:  660 682 1094 1119 420 451 87 94 144 151 56 42 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
88 new agents 
220 
disease_progression 
H-positive risk:  685 659 95 1126 448 86 1090 414 153 41 145 58 
H-negative risk:  659 685 1090 1126 414 448 86 95 145 153 58 41 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
221 
disease_progression 
H-positive risk:  681 665 97 1125 444 86 1088 416 154 42 147 55 
H-negative risk:  665 681 1088 1125 416 444 86 97 147 154 55 42 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
87 new agents 
222 
disease_progression 
H-positive risk:  684 672 100 1126 430 85 1085 420 154 42 147 55 
H-negative risk:  672 684 1085 1126 420 430 85 100 147 154 55 42 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 92 27 

clinical_engagement 
diagnosis 
demography 
84 new agents 
223 
disease_progression 
H-positive risk:  680 675 99 1136 428 83 1083 417 154 43 148 54 
H-negative risk:  675 680 1083 1136 417 428 83 99 148 154 54 43 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
224 
disease_progression 
H-positive risk:  678 672 101 1141 428 80 1076 425 152 44 148 55 
H-negative risk:  672 678 1076 1141 425 428 80 101 148 152 55 44 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
84 new agents 
225 
disease_progression 
H-positive risk:  689 667 100 1131 423 82 1072 440 147 45 149 55 
H-negative risk:  667 689 1072 1131 440 423 82 100 149 147 55 45 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 87 29 

clinical_engagement 
diagnosis 
demography 
60 new agents 
226 
disease_progression 
H-positive risk:  687 665 95 1128 430 80 1075 440 146 46 150 58 
H-negative risk:  665 687 1075 1128 440 430 80 95 150 146 58 46 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
227 
disease_progression 
H-positive risk:  699 669 95 1117 425 83 1075 438 147 47 149 56 
H-negative risk:  669 699 1075 1117 438 425 83 95 149 147 56 47 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
70 new agents 
228 
disease_progression 
H-positive risk:  687 658 97 1121 432 83 1081 438 145 50 150 58 
H-negative risk:  658 687 1081 1121 438 432 83 97 150 145 58 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
84 new agents 
229 
disease_progression 
H-positive risk:  686 659 97 1100 443 84 1068 459 147 52 145 60 
H-negative risk:  659 686 1068 1100 459 443 84 97 145 147 60 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
230 
disease_progression 
H-positive risk:  681 659 91 1099 443 84 1072 457 151 52 150 61 
H-negative risk:  659 681 1072 1099 457 443 84 91 150 151 61 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
231 
disease_progression 
H-positive risk:  684 647 91 1107 443 84 1079 452 150 51 147 65 
H-negative risk:  647 684 1079 1107 452 443 84 91 147 150 65 51 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
232 
disease_progression 
H-positive risk:  680 644 92 1113 445 84 1082 448 151 50 149 62 
H-negative risk:  644 680 1082 1113 448 445 84 92 149 151 62 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
233 
disease_progression 
H-positive risk:  681 640 96 1112 436 86 1089 448 149 52 146 65 
H-negative risk:  640 681 1089 1112 448 436 86 96 146 149 65 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
234 
disease_progression 
H-positive risk:  678 643 97 1105 438 85 1087 452 150 53 147 65 
H-negative risk:  643 678 1087 1105 452 438 85 97 147 150 65 53 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
235 
disease_progression 
H-positive risk:  674 640 96 1111 443 87 1083 450 149 51 149 67 
H-negative risk:  640 674 1083 1111 450 443 87 96 149 149 67 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
236 
disease_progression 
H-positive risk:  675 643 95 1112 439 84 1086 448 151 51 148 68 
H-negative risk:  643 675 1086 1112 448 439 84 95 148 151 68 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
237 
disease_progression 
H-positive risk:  680 645 97 1108 431 85 1093 446 147 54 147 67 
H-negative risk:  645 680 1093 1108 446 431 85 97 147 147 67 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
238 
disease_progression 
H-positive risk:  682 655 98 1096 427 87 1096 450 145 54 144 66 
H-negative risk:  655 682 1096 1096 450 427 87 98 144 145 66 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
239 
disease_progression 
H-positive risk:  681 661 99 1089 422 85 1111 441 146 55 145 65 
H-negative risk:  661 681 1111 1089 441 422 85 99 145 146 65 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
240 
disease_progression 
H-positive risk:  682 663 97 1092 417 83 1117 437 147 55 141 69 
H-negative risk:  663 682 1117 1092 437 417 83 97 141 147 69 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
241 
disease_progression 
H-positive risk:  679 669 98 1081 426 84 1103 450 144 59 139 68 
H-negative risk:  669 679 1103 1081 450 426 84 98 139 144 68 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
242 
disease_progression 
H-positive risk:  681 660 99 1087 421 82 1106 444 152 59 143 66 
H-negative risk:  660 681 1106 1087 444 421 82 99 143 152 66 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
243 
disease_progression 
H-positive risk:  685 656 98 1095 426 82 1096 445 150 58 144 65 
H-negative risk:  656 685 1096 1095 445 426 82 98 144 150 65 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
244 
disease_progression 
H-positive risk:  691 661 97 1090 434 84 1084 441 151 60 146 61 
H-negative risk:  661 691 1084 1090 441 434 84 97 146 151 61 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
245 
disease_progression 
H-positive risk:  696 669 93 1067 442 85 1096 435 150 57 150 60 
H-negative risk:  669 696 1096 1067 435 442 85 93 150 150 60 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
246 
disease_progression 
H-positive risk:  698 657 92 1076 438 82 1109 433 151 57 150 57 
H-negative risk:  657 698 1109 1076 433 438 82 92 150 151 57 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
247 
disease_progression 
H-positive risk:  698 653 88 1079 442 78 1109 435 152 58 150 58 
H-negative risk:  653 698 1109 1079 435 442 78 88 150 152 58 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
248 
disease_progression 
H-positive risk:  697 641 87 1082 446 77 1107 440 153 58 149 63 
H-negative risk:  641 697 1107 1082 440 446 77 87 149 153 63 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
249 
disease_progression 
H-positive risk:  698 641 84 1083 447 77 1105 438 153 56 154 64 
H-negative risk:  641 698 1105 1083 438 447 77 84 154 153 64 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
93 new agents 
250 
disease_progression 
H-positive risk:  700 646 84 1086 438 78 1097 438 154 58 157 64 
H-negative risk:  646 700 1097 1086 438 438 78 84 157 154 64 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
251 
disease_progression 
H-positive risk:  704 648 86 1084 426 76 1100 447 153 57 156 63 
H-negative risk:  648 704 1100 1084 447 426 76 86 156 153 63 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
252 
disease_progression 
H-positive risk:  702 649 87 1085 423 79 1095 453 150 58 157 62 
H-negative risk:  649 702 1095 1085 453 423 79 87 157 150 62 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
253 
disease_progression 
H-positive risk:  707 647 88 1088 424 79 1085 452 155 59 155 61 
H-negative risk:  647 707 1085 1088 452 424 79 88 155 155 61 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
254 
disease_progression 
H-positive risk:  702 648 88 1089 424 80 1090 447 156 61 155 60 
H-negative risk:  648 702 1090 1089 447 424 80 88 155 156 60 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
90 new agents 
255 
disease_progression 
H-positive risk:  705 656 91 1079 421 82 1080 451 156 62 156 61 
H-negative risk:  656 705 1080 1079 451 421 82 91 156 156 61 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
256 
disease_progression 
H-positive risk:  696 651 90 1083 424 84 1090 446 155 63 156 62 
H-negative risk:  651 696 1090 1083 446 424 84 90 156 155 62 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
257 
disease_progression 
H-positive risk:  696 647 91 1085 422 86 1095 447 155 60 156 60 
H-negative risk:  647 696 1095 1085 447 422 86 91 156 155 60 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
258 
disease_progression 
H-positive risk:  686 644 92 1085 424 87 1097 451 157 58 156 63 
H-negative risk:  644 686 1097 1085 451 424 87 92 156 157 63 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
259 
disease_progression 
H-positive risk:  694 641 90 1083 424 88 1098 446 156 60 157 63 
H-negative risk:  641 694 1098 1083 446 424 88 90 157 156 63 60 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
260 
disease_progression 
H-positive risk:  698 638 91 1093 421 88 1102 439 156 55 155 64 
H-negative risk:  638 698 1102 1093 439 421 88 91 155 156 64 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
261 
disease_progression 
H-positive risk:  697 645 91 1086 424 89 1105 429 159 55 156 64 
H-negative risk:  645 697 1105 1086 429 424 89 91 156 159 64 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
262 
disease_progression 
H-positive risk:  692 642 92 1090 419 93 1110 422 159 58 157 66 
H-negative risk:  642 692 1110 1090 422 419 93 92 157 159 66 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
263 
disease_progression 
H-positive risk:  690 640 95 1092 423 96 1106 422 156 61 157 62 
H-negative risk:  640 690 1106 1092 422 423 96 95 157 156 62 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
264 
disease_progression 
H-positive risk:  691 642 91 1091 417 95 1107 432 154 62 156 62 
H-negative risk:  642 691 1107 1091 432 417 95 91 156 154 62 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
265 
disease_progression 
H-positive risk:  689 646 89 1089 417 96 1109 430 156 61 154 64 
H-negative risk:  646 689 1109 1089 430 417 96 89 154 156 64 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
266 
disease_progression 
H-positive risk:  689 647 88 1085 420 97 1116 430 153 59 156 60 
H-negative risk:  647 689 1116 1085 430 420 97 88 156 153 60 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
267 
disease_progression 
H-positive risk:  686 650 89 1094 412 95 1113 430 153 63 156 59 
H-negative risk:  650 686 1113 1094 430 412 95 89 156 153 59 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
268 
disease_progression 
H-positive risk:  688 647 90 1097 414 96 1102 435 158 61 152 60 
H-negative risk:  647 688 1102 1097 435 414 96 90 152 158 60 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
269 
disease_progression 
H-positive risk:  682 646 88 1097 422 98 1097 436 156 62 158 58 
H-negative risk:  646 682 1097 1097 436 422 98 88 158 156 58 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
270 
disease_progression 
H-positive risk:  684 653 86 1094 427 101 1094 427 154 64 159 57 
H-negative risk:  653 684 1094 1094 427 427 101 86 159 154 57 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
90 new agents 
271 
disease_progression 
H-positive risk:  697 658 86 1078 431 103 1094 424 149 65 158 57 
H-negative risk:  658 697 1094 1078 424 431 103 86 158 149 57 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
272 
disease_progression 
H-positive risk:  700 656 89 1064 437 101 1096 428 153 64 156 56 
H-negative risk:  656 700 1096 1064 428 437 101 89 156 153 56 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
273 
disease_progression 
H-positive risk:  700 659 94 1061 439 101 1090 424 153 65 156 58 
H-negative risk:  659 700 1090 1061 424 439 101 94 156 153 58 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
274 
disease_progression 
H-positive risk:  703 650 92 1067 444 104 1076 427 155 65 158 59 
H-negative risk:  650 703 1076 1067 427 444 104 92 158 155 59 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
275 
disease_progression 
H-positive risk:  716 651 91 1057 449 100 1076 427 155 63 158 57 
H-negative risk:  651 716 1076 1057 427 449 100 91 158 155 57 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
276 
disease_progression 
H-positive risk:  715 655 92 1058 453 102 1073 427 151 60 159 55 
H-negative risk:  655 715 1073 1058 427 453 102 92 159 151 55 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
277 
disease_progression 
H-positive risk:  710 656 89 1066 456 101 1080 415 153 60 162 52 
H-negative risk:  656 710 1080 1066 415 456 101 89 162 153 52 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
278 
disease_progression 
H-positive risk:  715 653 90 1070 453 102 1083 409 151 59 163 52 
H-negative risk:  653 715 1083 1070 409 453 102 90 163 151 52 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
58 new agents 
279 
disease_progression 
H-positive risk:  709 650 88 1071 453 101 1091 413 150 60 164 50 
H-negative risk:  650 709 1091 1071 413 453 101 88 164 150 50 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
280 
disease_progression 
H-positive risk:  713 646 88 1068 461 100 1083 417 151 59 163 51 
H-negative risk:  646 713 1083 1068 417 461 100 88 163 151 51 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
97 new agents 
281 
disease_progression 
H-positive risk:  712 649 89 1067 455 100 1071 418 153 66 166 54 
H-negative risk:  649 712 1071 1067 418 455 100 89 166 153 54 66 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
282 
disease_progression 
H-positive risk:  719 647 90 1067 451 99 1077 409 155 66 164 56 
H-negative risk:  647 719 1077 1067 409 451 99 90 164 155 56 66 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
283 
disease_progression 
H-positive risk:  718 653 93 1068 444 100 1071 408 155 67 165 58 
H-negative risk:  653 718 1071 1068 408 444 100 93 165 155 58 67 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
284 
disease_progression 
H-positive risk:  714 655 94 1076 432 106 1074 411 150 66 164 58 
H-negative risk:  655 714 1074 1076 411 432 106 94 164 150 58 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
285 
disease_progression 
H-positive risk:  723 654 94 1066 431 104 1080 411 151 64 166 56 
H-negative risk:  654 723 1080 1066 411 431 104 94 166 151 56 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
286 
disease_progression 
H-positive risk:  724 661 93 1058 428 105 1075 413 153 65 170 55 
H-negative risk:  661 724 1075 1058 413 428 105 93 170 153 55 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
287 
disease_progression 
H-positive risk:  726 663 92 1053 427 105 1073 420 153 64 169 55 
H-negative risk:  663 726 1073 1053 420 427 105 92 169 153 55 64 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
288 
disease_progression 
H-positive risk:  731 665 90 1050 420 101 1064 430 157 64 172 56 
H-negative risk:  665 731 1064 1050 430 420 101 90 172 157 56 64 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
289 
disease_progression 
H-positive risk:  732 672 93 1045 417 98 1067 428 158 65 169 56 
H-negative risk:  672 732 1067 1045 428 417 98 93 169 158 56 65 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
290 
disease_progression 
H-positive risk:  736 666 93 1045 419 99 1072 423 153 66 172 56 
H-negative risk:  666 736 1072 1045 423 419 99 93 172 153 56 66 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
291 
disease_progression 
H-positive risk:  739 668 96 1042 420 97 1069 420 154 66 170 59 
H-negative risk:  668 739 1069 1042 420 420 97 96 170 154 59 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
292 
disease_progression 
H-positive risk:  746 671 97 1041 424 98 1069 412 153 63 167 59 
H-negative risk:  671 746 1069 1041 412 424 98 97 167 153 59 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
47 new agents 
293 
disease_progression 
H-positive risk:  748 667 95 1036 431 99 1071 412 154 63 167 57 
H-negative risk:  667 748 1071 1036 412 431 99 95 167 154 57 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
294 
disease_progression 
H-positive risk:  750 657 96 1038 430 98 1076 416 151 62 164 62 
H-negative risk:  657 750 1076 1038 416 430 98 96 164 151 62 62 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 87 28 

clinical_engagement 
diagnosis 
demography 
88 new agents 
295 
disease_progression 
H-positive risk:  750 658 93 1043 419 103 1081 413 151 63 162 64 
H-negative risk:  658 750 1081 1043 413 419 103 93 162 151 64 63 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
62 new agents 
296 
disease_progression 
H-positive risk:  747 660 92 1038 415 105 1083 419 151 64 161 65 
H-negative risk:  660 747 1083 1038 419 415 105 92 161 151 65 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 87 28 

clinical_engagement 
diagnosis 
demography 
63 new agents 
297 
disease_progression 
H-positive risk:  741 659 92 1038 409 103 1087 425 154 66 162 64 
H-negative risk:  659 741 1087 1038 425 409 103 92 162 154 64 66 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
298 
disease_progression 
H-positive risk:  750 661 91 1038 408 105 1077 421 152 68 162 67 
H-negative risk:  661 750 1077 1038 421 408 105 91 162 152 67 68 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
299 
disease_progression 
H-positive risk:  750 659 89 1046 408 101 1074 424 154 66 161 68 
H-negative risk:  659 750 1074 1046 424 408 101 89 161 154 68 66 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
300 
disease_progression 
H-positive risk:  748 658 92 1041 417 100 1077 423 153 66 159 66 
H-negative risk:  658 748 1077 1041 423 417 100 92 159 153 66 66 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
92 new agents 
301 
disease_progression 
H-positive risk:  752 663 91 1039 418 102 1071 422 152 63 157 70 
H-negative risk:  663 752 1071 1039 422 418 102 91 157 152 70 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
90 new agents 
302 
disease_progression 
H-positive risk:  752 669 90 1030 416 104 1077 416 156 63 159 68 
H-negative risk:  669 752 1077 1030 416 416 104 90 159 156 68 63 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 86 34 

clinical_engagement 
diagnosis 
demography 
72 new agents 
303 
disease_progression 
H-positive risk:  746 666 92 1026 416 105 1087 419 154 61 159 69 
H-negative risk:  666 746 1087 1026 419 416 105 92 159 154 69 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 85 32 

clinical_engagement 
diagnosis 
demography 
102 new agents 
304 
disease_progression 
H-positive risk:  750 670 89 1022 413 105 1091 409 160 61 163 67 
H-negative risk:  670 750 1091 1022 409 413 105 89 163 160 67 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 83 34 

clinical_engagement 
diagnosis 
demography 
70 new agents 
305 
disease_progression 
H-positive risk:  744 671 87 1022 416 104 1096 411 157 64 163 65 
H-negative risk:  671 744 1096 1022 411 416 104 87 163 157 65 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 78 34 

clinical_engagement 
diagnosis 
demography 
78 new agents 
306 
disease_progression 
H-positive risk:  736 670 88 1027 409 104 1110 407 153 67 166 63 
H-negative risk:  670 736 1110 1027 407 409 104 88 166 153 63 67 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
307 
disease_progression 
H-positive risk:  735 668 86 1023 410 106 1112 409 153 71 164 63 
H-negative risk:  668 735 1112 1023 409 410 106 86 164 153 63 71 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
87 new agents 
308 
disease_progression 
H-positive risk:  742 667 88 1019 401 105 1113 417 153 69 165 61 
H-negative risk:  667 742 1113 1019 417 401 105 88 165 153 61 69 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
309 
disease_progression 
H-positive risk:  750 664 86 1014 405 105 1108 423 153 67 164 61 
H-negative risk:  664 750 1108 1014 423 405 105 86 164 153 61 67 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
310 
disease_progression 
H-positive risk:  748 665 84 1014 402 107 1110 428 157 65 162 58 
H-negative risk:  665 748 1110 1014 428 402 107 84 162 157 58 65 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
311 
disease_progression 
H-positive risk:  750 660 87 1020 400 109 1113 427 154 64 160 56 
H-negative risk:  660 750 1113 1020 427 400 109 87 160 154 56 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
312 
disease_progression 
H-positive risk:  748 663 84 1010 410 110 1108 427 158 65 161 56 
H-negative risk:  663 748 1108 1010 427 410 110 84 161 158 56 65 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
313 
disease_progression 
H-positive risk:  746 667 89 1006 419 107 1100 426 160 65 158 57 
H-negative risk:  667 746 1100 1006 426 419 107 89 158 160 57 65 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
314 
disease_progression 
H-positive risk:  747 672 94 1006 421 108 1090 431 157 63 155 56 
H-negative risk:  672 747 1090 1006 431 421 108 94 155 157 56 63 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
315 
disease_progression 
H-positive risk:  745 672 92 1003 417 105 1099 432 161 63 152 59 
H-negative risk:  672 745 1099 1003 432 417 105 92 152 161 59 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
316 
disease_progression 
H-positive risk:  749 665 94 1004 421 104 1098 431 158 61 155 60 
H-negative risk:  665 749 1098 1004 431 421 104 94 155 158 60 61 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
317 
disease_progression 
H-positive risk:  739 664 94 1005 430 101 1097 437 157 63 153 60 
H-negative risk:  664 739 1097 1005 437 430 101 94 153 157 60 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
318 
disease_progression 
H-positive risk:  743 670 94 1001 434 101 1096 432 158 63 151 57 
H-negative risk:  670 743 1096 1001 432 434 101 94 151 158 57 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
84 new agents 
319 
disease_progression 
H-positive risk:  743 667 94 1006 434 101 1093 430 161 64 148 59 
H-negative risk:  667 743 1093 1006 430 434 101 94 148 161 59 64 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
320 
disease_progression 
H-positive risk:  734 665 97 1013 432 104 1089 434 159 65 146 62 
H-negative risk:  665 734 1089 1013 434 432 104 97 146 159 62 65 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
321 
disease_progression 
H-positive risk:  712 670 98 1013 433 105 1099 440 157 65 143 65 
H-negative risk:  670 712 1099 1013 440 433 105 98 143 157 65 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
322 
disease_progression 
H-positive risk:  711 662 99 1023 435 105 1092 441 163 63 140 66 
H-negative risk:  662 711 1092 1023 441 435 105 99 140 163 66 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
323 
disease_progression 
H-positive risk:  704 664 104 1017 430 108 1093 445 161 64 142 68 
H-negative risk:  664 704 1093 1017 445 430 108 104 142 161 68 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
324 
disease_progression 
H-positive risk:  702 669 102 1021 422 107 1096 444 160 64 144 69 
H-negative risk:  669 702 1096 1021 444 422 107 102 144 160 69 64 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
325 
disease_progression 
H-positive risk:  695 666 100 1040 412 108 1106 436 159 65 148 65 
H-negative risk:  666 695 1106 1040 436 412 108 100 148 159 65 65 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
326 
disease_progression 
H-positive risk:  691 669 94 1058 405 107 1102 433 157 64 154 66 
H-negative risk:  669 691 1102 1058 433 405 107 94 154 157 66 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
327 
disease_progression 
H-positive risk:  692 666 95 1058 402 105 1105 432 158 65 153 69 
H-negative risk:  666 692 1105 1058 432 402 105 95 153 158 69 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
328 
disease_progression 
H-positive risk:  691 666 96 1056 398 104 1115 430 156 68 155 65 
H-negative risk:  666 691 1115 1056 430 398 104 96 155 156 65 68 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
329 
disease_progression 
H-positive risk:  699 664 94 1051 406 105 1109 426 155 72 155 64 
H-negative risk:  664 699 1109 1051 426 406 105 94 155 155 64 72 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
97 new agents 
330 
disease_progression 
H-positive risk:  692 671 95 1057 395 110 1121 416 154 71 156 62 
H-negative risk:  671 692 1121 1057 416 395 110 95 156 154 62 71 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
331 
disease_progression 
H-positive risk:  699 664 94 1071 384 110 1111 424 156 69 157 61 
H-negative risk:  664 699 1111 1071 424 384 110 94 157 156 61 69 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
332 
disease_progression 
H-positive risk:  705 675 95 1071 382 110 1096 424 157 68 158 59 
H-negative risk:  675 705 1096 1071 424 382 110 95 158 157 59 68 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
333 
disease_progression 
H-positive risk:  704 667 95 1079 385 109 1097 419 160 69 158 58 
H-negative risk:  667 704 1097 1079 419 385 109 95 158 160 58 69 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
334 
disease_progression 
H-positive risk:  708 666 98 1089 385 109 1087 413 160 70 156 59 
H-negative risk:  666 708 1087 1089 413 385 109 98 156 160 59 70 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
335 
disease_progression 
H-positive risk:  704 671 98 1090 379 109 1094 412 159 69 156 59 
H-negative risk:  671 704 1094 1090 412 379 109 98 156 159 59 69 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
336 
disease_progression 
H-positive risk:  705 679 97 1080 384 108 1091 416 158 69 157 56 
H-negative risk:  679 705 1091 1080 416 384 108 97 157 158 56 69 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
337 
disease_progression 
H-positive risk:  716 671 96 1074 388 108 1092 413 159 70 156 57 
H-negative risk:  671 716 1092 1074 413 388 108 96 156 159 57 70 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
338 
disease_progression 
H-positive risk:  720 677 96 1078 385 106 1075 414 161 72 158 58 
H-negative risk:  677 720 1075 1078 414 385 106 96 158 161 58 72 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
339 
disease_progression 
H-positive risk:  727 678 97 1080 387 108 1069 408 159 72 155 60 
H-negative risk:  678 727 1069 1080 408 387 108 97 155 159 60 72 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
340 
disease_progression 
H-positive risk:  728 671 99 1082 391 108 1076 398 159 76 152 60 
H-negative risk:  671 728 1076 1082 398 391 108 99 152 159 60 76 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
341 
disease_progression 
H-positive risk:  729 673 98 1082 390 110 1074 400 159 74 152 59 
H-negative risk:  673 729 1074 1082 400 390 110 98 152 159 59 74 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
342 
disease_progression 
H-positive risk:  728 673 95 1090 384 110 1074 405 158 68 153 62 
H-negative risk:  673 728 1074 1090 405 384 110 95 153 158 62 68 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
343 
disease_progression 
H-positive risk:  721 677 95 1097 388 112 1071 401 160 68 150 60 
H-negative risk:  677 721 1071 1097 401 388 112 95 150 160 60 68 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
344 
disease_progression 
H-positive risk:  719 669 97 1089 389 109 1072 412 166 67 154 57 
H-negative risk:  669 719 1072 1089 412 389 109 97 154 166 57 67 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
345 
disease_progression 
H-positive risk:  713 668 95 1094 394 108 1074 404 166 66 160 58 
H-negative risk:  668 713 1074 1094 404 394 108 95 160 166 58 66 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
346 
disease_progression 
H-positive risk:  728 675 93 1084 392 107 1068 407 167 64 152 63 
H-negative risk:  675 728 1068 1084 407 392 107 93 152 167 63 64 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
347 
disease_progression 
H-positive risk:  727 672 92 1089 393 104 1081 398 165 67 155 57 
H-negative risk:  672 727 1081 1089 398 393 104 92 155 165 57 67 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
348 
disease_progression 
H-positive risk:  719 671 92 1087 394 104 1094 398 164 66 155 56 
H-negative risk:  671 719 1094 1087 398 394 104 92 155 164 56 66 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 64 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
349 
disease_progression 
H-positive risk:  718 674 92 1088 389 105 1084 405 166 65 155 59 
H-negative risk:  674 718 1084 1088 405 389 105 92 155 166 59 65 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 65 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
350 
disease_progression 
H-positive risk:  719 669 90 1091 391 107 1088 406 160 64 156 59 
H-negative risk:  669 719 1088 1091 406 391 107 90 156 160 59 64 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 65 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
351 
disease_progression 
H-positive risk:  714 675 89 1090 388 106 1092 411 157 66 152 60 
H-negative risk:  675 714 1092 1090 411 388 106 89 152 157 60 66 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
352 
disease_progression 
H-positive risk:  710 678 87 1096 382 107 1090 416 155 63 156 60 
H-negative risk:  678 710 1090 1096 416 382 107 87 156 155 60 63 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
353 
disease_progression 
H-positive risk:  710 676 90 1094 384 105 1090 416 157 64 154 60 
H-negative risk:  676 710 1090 1094 416 384 105 90 154 157 60 64 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
354 
disease_progression 
H-positive risk:  707 666 93 1102 382 108 1086 424 153 65 155 59 
H-negative risk:  666 707 1086 1102 424 382 108 93 155 153 59 65 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
355 
disease_progression 
H-positive risk:  706 664 91 1112 383 107 1079 421 155 68 157 57 
H-negative risk:  664 706 1079 1112 421 383 107 91 157 155 57 68 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 63 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
356 
disease_progression 
H-positive risk:  705 668 92 1121 383 106 1078 415 150 65 160 57 
H-negative risk:  668 705 1078 1121 415 383 106 92 160 150 57 65 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 65 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
357 
disease_progression 
H-positive risk:  700 665 90 1122 381 106 1075 425 149 67 164 56 
H-negative risk:  665 700 1075 1122 425 381 106 90 164 149 56 67 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 63 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
358 
disease_progression 
H-positive risk:  703 661 91 1137 370 104 1071 430 149 66 163 55 
H-negative risk:  661 703 1071 1137 430 370 104 91 163 149 55 66 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 63 20 

clinical_engagement 
diagnosis 
demography 
95 new agents 
359 
disease_progression 
H-positive risk:  703 663 90 1144 377 104 1074 420 147 65 159 54 
H-negative risk:  663 703 1074 1144 420 377 104 90 159 147 54 65 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 58 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
360 
disease_progression 
H-positive risk:  710 667 93 1140 379 105 1064 421 143 67 158 53 
H-negative risk:  667 710 1064 1140 421 379 105 93 158 143 53 67 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 57 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
Time difference of 18.12579 mins
This is task 18
date
